Danaher Corporation (NYSE:DHR) insider William King sold 7,458 shares of the firm’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now owns 18,245 shares in the company, valued at $1,513,787.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Shares of Danaher Corporation (NYSE:DHR) opened at 80.87 on Friday. Danaher Corporation has a one year low of $75.71 and a one year high of $88.01. The stock has a market cap of $56.18 billion, a price-to-earnings ratio of 25.81 and a beta of 1.03. The firm has a 50-day moving average price of $82.32 and a 200-day moving average price of $84.22.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. During the same quarter last year, the business earned $0.90 earnings per share. Danaher Corporation’s revenue was up 6.3% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This article was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.com-unik.info/2017/08/19/danaher-corporation-dhr-insider-william-king-sells-7458-shares-updated-updated-updated.html.
A number of analysts have weighed in on DHR shares. Royal Bank Of Canada restated a “sector perform” rating and issued a $88.00 price target (down from $89.00) on shares of Danaher Corporation in a research note on Friday, April 21st. Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Friday, April 21st. BTIG Research reiterated a “buy” rating and set a $92.00 target price on shares of Danaher Corporation in a research report on Sunday, April 23rd. Cowen and Company reiterated an “outperform” rating and set a $90.00 target price on shares of Danaher Corporation in a research report on Sunday, April 23rd. Finally, William Blair reiterated an “outperform” rating on shares of Danaher Corporation in a research report on Sunday, April 23rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Danaher Corporation presently has an average rating of “Buy” and an average price target of $91.76.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.